These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 21670515)
1. Production of a recombinant full-length prion protein in a soluble form without refolding or detergents. Arii Y; Oshiro S; Wada K; Fukuoka S Biosci Biotechnol Biochem; 2011; 75(6):1181-3. PubMed ID: 21670515 [TBL] [Abstract][Full Text] [Related]
2. Heat-shock protein fusion vectors for improved expression of soluble recombinant proteins in Escherichia coli. Kyratsous CA; Panagiotidis CA Methods Mol Biol; 2012; 824():109-29. PubMed ID: 22160895 [TBL] [Abstract][Full Text] [Related]
4. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein. Hornemann S; Glockshuber R J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210 [TBL] [Abstract][Full Text] [Related]
5. Production of a soluble recombinant prion protein fused to blue fluorescent protein without refolding or detergents in Escherichia coli cells. Arii Y; Yamaguchi H; Fukuoka S Biosci Biotechnol Biochem; 2007 Oct; 71(10):2511-4. PubMed ID: 17928700 [TBL] [Abstract][Full Text] [Related]
6. Production, purification and oxidative folding of the mouse recombinant prion protein. Pavlícek A; Bednárová L; Holada K Folia Microbiol (Praha); 2007; 52(4):391-7. PubMed ID: 18062188 [TBL] [Abstract][Full Text] [Related]
7. Penicillin-binding protein 2a of Streptococcus pneumoniae: expression in Escherichia coli and purification and refolding of inclusion bodies into a soluble and enzymatically active enzyme. Zhao G; Meier TI; Hoskins J; Jaskunas SR Protein Expr Purif; 1999 Jul; 16(2):331-9. PubMed ID: 10419829 [TBL] [Abstract][Full Text] [Related]
8. On-column purification and refolding of recombinant bovine prion protein: using its octarepeat sequences as a natural affinity tag. Yin SM; Zheng Y; Tien P Protein Expr Purif; 2003 Nov; 32(1):104-9. PubMed ID: 14680946 [TBL] [Abstract][Full Text] [Related]
9. Resistance of cell lines to prion toxicity aided by phospho-ERK expression. Uppington KM; Brown DR J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369 [TBL] [Abstract][Full Text] [Related]
10. Enhanced neuroinvasion by smaller, soluble prions. Bett C; Lawrence J; Kurt TD; Orru C; Aguilar-Calvo P; Kincaid AE; Surewicz WK; Caughey B; Wu C; Sigurdson CJ Acta Neuropathol Commun; 2017 Apr; 5(1):32. PubMed ID: 28431576 [TBL] [Abstract][Full Text] [Related]
11. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli. Cao P; Mei JJ; Diao ZY; Zhang Sq Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238 [TBL] [Abstract][Full Text] [Related]
12. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli. Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894 [TBL] [Abstract][Full Text] [Related]
13. Purification and fibrillation of full-length recombinant PrP. Makarava N; Baskakov IV Methods Mol Biol; 2012; 849():33-52. PubMed ID: 22528082 [TBL] [Abstract][Full Text] [Related]
14. An efficient in vitro refolding of recombinant bacterial laccase in Escherichia coli. Mollania N; Khajeh K; Ranjbar B; Rashno F; Akbari N; Fathi-Roudsari M Enzyme Microb Technol; 2013 May; 52(6-7):325-30. PubMed ID: 23608500 [TBL] [Abstract][Full Text] [Related]
15. Expression and detection strategies for an scFv fragment retaining the same high affinity than Fab and whole antibody: Implications for therapeutic use in prion diseases. Padiolleau-Lefevre S; Alexandrenne C; Dkhissi F; Clement G; Essono S; Blache C; Couraud JY; Wijkhuisen A; Boquet D Mol Immunol; 2007 Mar; 44(8):1888-96. PubMed ID: 17140664 [TBL] [Abstract][Full Text] [Related]
16. Copper refolding of prion protein. Wong BS; Vénien-Bryan C; Williamson RA; Burton DR; Gambetti P; Sy MS; Brown DR; Jones IM Biochem Biophys Res Commun; 2000 Oct; 276(3):1217-24. PubMed ID: 11027613 [TBL] [Abstract][Full Text] [Related]
17. Purification and on-column refolding of EGFP overexpressed as inclusion bodies in Escherichia coli with expanded bed anion exchange chromatography. Cabanne C; Noubhani AM; Hocquellet A; Dole F; Dieryck W; Santarelli X J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(1):23-7. PubMed ID: 15722040 [TBL] [Abstract][Full Text] [Related]
18. Coexpression of chaperonin GroEL/GroES markedly enhanced soluble and functional expression of recombinant human interferon-gamma in Escherichia coli. Yan X; Hu S; Guan YX; Yao SJ Appl Microbiol Biotechnol; 2012 Feb; 93(3):1065-74. PubMed ID: 21975693 [TBL] [Abstract][Full Text] [Related]
19. Expression, purification of human vasostatin120-180 in Escherichia coli, and its anti-angiogenic characterization. Sun QM; Cao L; Fang L; Chen C; Dai J; Chen LL; Hua ZC Protein Expr Purif; 2005 Feb; 39(2):288-95. PubMed ID: 15642481 [TBL] [Abstract][Full Text] [Related]
20. Production of recombinant serpins in Escherichia coli. Pearce MC; Cabrita LD Methods Enzymol; 2011; 501():13-28. PubMed ID: 22078528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]